A recent development in the medical field has sparked interest, with a panel of outside experts advising the US Food and Drug Administration. The experts recommended increasing public access to certain peptides. This recommendation is notable as it goes against the advice of the FDA's own scientists, who have expressed safety concerns.

Further details on this story, including the types of peptides in question and the potential implications, are available from KTVU FOX 2 News in San Francisco.